Next Gen RNA
Vaccines and Therapeutics
Tiba Biotech is advancing the RNA medicine field with an improved approach to nucleic acid delivery.
Fully biodegradable nanoparticle delivery platform for safer vaccines and therapeutics
Computational RNA design for more potent gene expression
Better patient outcomes through rational design, from gene to delivery method
Novel delivery platform
5+ years government sponsored research
Vaccines and therapeutics
Broad range of applications
Advanced RNA Design
State-of-the-art engineering
CORE INNOVATIONIntegrated nanoparticle delivery and nucleic acid design
Enabling life-saving vaccines and new areas of therapeutic impact
Tiba Biotech is developing a range of novel RNA medicines, with initial focus on vaccines and expanding to high-impact therapeutics. Our collaborators and strategic partners include:
- United States National Institute of Health (NIH)
- Collaborative Influenza Vaccine Innovation Centers (CIVICs)
- Biomedical Advanced Research and Development Authority (BARDA)
- Coalition for Epidemic Preparedness Innovations (CEPI)
- NSW Department of Primary Industries and Regional Development (DPIRD)
BEYOND VACCINESLeveraging High-efficiency Next Generation RNA Delivery for Therapeutic Applications
Engaged in early discovery of immuno-oncology and gene delivery
Keep connected with us
© 2024 Tiba Biotech LLC. All rights reserved